HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Infectious Diseases

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/433188PMID 16142675
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon?

  2005cited by this paper
• Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.

  2005cited by this paper
• Persistent GB virus C infection and survival in HIV-infected men.

  2004influential reference
• Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

  2004influential reference
• HIV-host interactions: vital to the virus and key to its inhibition.

  2004cited by this paper
• Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

  2003cited by this paper
• Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection.

  2003cited by this paper
• HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

  2002cited by this paper
• Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity

  2001cited by this paper
• Host Determinants in HIV Infection and Disease: Part 1: Cellular and Humoral Immune Responses*

  2001influential reference
• High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation

  2001cited by this paper
• HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

  2000influential reference
• Broad, Intense Anti-Human Immunodeficiency Virus (HIV) Ex Vivo CD8+ Responses in HIV Type 1-Infected Patients: Comparison with Anti-Epstein-Barr Virus Responses and Changes during Antiretroviral Therapy

  1999cited by this paper
• Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort.

  1999cited by this paper
• Early protective effect of CCR‐5 Δ32 heterozygosity on HIV‐1 disease progression: relationship with viral load

  1997cited by this paper
• Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.

  1997influential reference
• Male circumcision and susceptibility to HIV infection among men in Tanzania

  1997cited by this paper
• Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.

  1997cited by this paper
• Male circumcision and susceptibility to HIV infection among men in Tanzania.

  1997cited by this paper
• Lack of consistency between five definitions of nonprogression in cohorts of HIV-infected seroconverters

  1996cited by this paper
• Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.

  1995cited by this paper

• The elite controller phenotype.

  2026cites this paper
• Cox-Integrated Spline Sieve Estimation for Doubly Censored Cure Models

  2026cites this paper
• The HIV reservoir landscape in elite controllers.

  2026cites this paper
• HIV controllers, lessons learnt from the lymphoid tissues.

  2026cites this paper
• Learning from nature: HIV elite controllers as blueprints for a functional cure

  2025cites this paper
• DNA methylation landscapes of HIV controllers: an epigenome-wide association study

  2025cites this paper
• From network biology to immunity: potential longitudinal biomarkers for targeting the network topology of the HIV reservoir

  2025cites this paper
• HIV-1 controllers possess a unique CD8+ T cell activation phenotype and loss of control is associated with increased expression of exhaustion markers

  2025cites this paper
• Acute HIV-1 Infection: Paradigm and Singularity

  2025cites this paper
• Circulating immune landscape and immune signatures in spontaneous HIV controllers

  2025cites this paper
• Higher plasma concentrations of von Willebrand factor in women than in men during both the acute and chronic phases of HIV infection.

  2025cites this paper
• The functional antibody landscape in HIV post-treatment controllers is heterogeneous

  2025influential citation
• IFNα induces CCR5 in CD4+ T cells of HIV patients causing pathogenic elevation

  2024influential citation
• Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers

  2024cites this paper
• Elite controllers microbiome: unraveling the mystery of association and causation

  2024cites this paper
• CXCR3-Expressing T Cells in Infections and Autoimmunity.

  2024cites this paper
• Exceptional, naturally occurring HIV-1 control: Insight into a functional cure

  2024cites this paper
• Research Toward a Cure for Perinatal HIV.

  2024cites this paper
• Advancing Human Vaccine Development Using Humanized Mouse Models

  2024cites this paper
• Helper T cell immunity in humans with inherited CD4 deficiency

  2024cites this paper
• Distinguishable topology of the task-evoked functional genome networks in HIV-1 reservoirs

  2024cites this paper
• Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection

  2024cites this paper
• The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

  2024cites this paper
• An open label randomized controlled trial of atorvastatin versus aspirin in elite controllers and antiretroviral-treated people with HIV

  2023cites this paper
• Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging

  2023cites this paper
• IFNα induces CCR5 in CD4+ T-cells, causing its anti- HIV inefficiency and its subsequent pathogenic elevation, partially controlled by anti-HIV therapy

  2023cites this paper
• TScan-II: A genome-scale platform for the de novo identification of CD4+ T cell epitopes.

  2023cites this paper
• Comparison of the Biological Basis for Non-HIV Transmission to HIV-Exposed Seronegative Individuals, Disease Non-Progression in HIV Long-Term Non-Progressors and Elite Controllers

  2023cites this paper
• Detection of unreported usage of the antiretroviral drug lamivudine in two blood donors

  2023cites this paper
• An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8+ T cell magnitude and short-lived differentiation status

  2023cites this paper
• Laboratory diagnosis of HIV: a contemporary overview in the Australian context.

  2023cites this paper
• Targeting the HIV reservoir: chimeric antigen receptor therapy for HIV cure

  2023cites this paper
• Impact of predicted HLA class I immunopeptidome on viral reservoir in a cohort of people living with HIV in Italy

  2023cites this paper
• Bibliometric and visualized analysis of elite controllers based on CiteSpace: landscapes, hotspots, and frontiers

  2023cites this paper
• Molecular insights into the HLA‐B35 molecules' classification associated with HIV control

  2023cites this paper
• Population‐level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART)

  2023cites this paper
• A metagenome-wide association study of HIV disease progression in HIV controllers

  2023cites this paper
• CD8+ T-cell responses in HIV controllers: potential implications for novel HIV remission strategies

  2022cites this paper
• Protective HLA-B57: T cell and natural killer cell recognition in HIV infection

  2022cites this paper
• Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

  2022cites this paper
• Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands

  2022cites this paper
• Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression

  2022cites this paper
• HIV-1-Associated Kidney Disease in an Elite Controller

  2022cites this paper
• Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry

  2022cites this paper
• Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control

  2022cites this paper
• TCR-mimic bispecific antibodies to target the HIV-1 reservoir

  2022cites this paper
• Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative Study

  2022cites this paper
• Dynamical Analysis of Posttreatment HIV‐1 Infection Model

  2022cites this paper
• HIV vaccinology: 2021 update.

  2021cites this paper
• Killer immunoglobulin-like receptor (KIR) genes are associated with the risk of episodes of high-level and detectable viremia among HIV controllers

  2021cites this paper
• Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.

  2021cites this paper
• Antiretroviral therapy for HIV controllers: Reasons for initiation and outcomes in the French ANRS-CO21 CODEX cohort

  2021cites this paper
• P-Selectin Glycoprotein Ligand 1: A Potential HIV-1 Therapeutic Target

  2021cites this paper
• SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise

  2021cites this paper
• CXCR3 and CXCR5 are highly expressed in HIV‐1‐specific CD8 central memory T cells from infected patients

  2021cites this paper
• Initiation of Antiretroviral Therapy in HIV Elite Controller: A Case Report from Limpopo Province, South Africa A Case

  2021cites this paper
• Unified model of short- and long-term HIV viral rebound for clinical trial planning

  2021cites this paper
• Models of increased latent HIV reservoir turnover prior to cART initiation imply novel clearance strategies

  2021cites this paper
• The Interplay of HIV and Autophagy in Early Infection

  2021cites this paper
• Evaluation of the expression pattern of 4 microRNAs and their correlation with cellular/viral factors in PBMCs of Long Term non-progressors and HIV infected naïve Individuals.

  2021cites this paper
• High rates of long‐term progression in HIV‐1‐positive elite controllers

  2021cites this paper
• Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

  2021cites this paper
• A role for CD4 helper cells in HIV control and progression

  2021cites this paper
• Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice

  2021cites this paper
• Elite and viremic HIV-1 controllers in West Africa

  2021cites this paper
• Distinct antibody profiles in HLA-B∗57+, HLA-B∗57− HIV controllers and chronic progressors

  2021cites this paper
• Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors

  2021cites this paper
• Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflect the Severity for the Acute and Chronic Infectious Diseases

  2021cites this paper
• Incoming HIV Virion-Derived Gag Spacer Peptide 2 (p1) is a Target of Effective CD8+ T Cell Antiviral Responses

  2020cites this paper
• Resistance to human immunodeficiency virus infection: a rare but neglected state

  2020cites this paper
• The importance of advanced cytometry in defining new immune cell types and functions relevant for the immunopathogenesis of HIV infection.

  2020cites this paper
• Identification of molecular mechanisms for achieving HIV-1 control in the absence of antiretroviral therapy.

  2020cites this paper
• Persistent HIV‐controllers are more prone to spontaneously clear HCV: a retrospective cohort study

  2020cites this paper
• Elite controllers: A heterogeneous group of HIV-infected patients

  2020cites this paper
• Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases

  2020cites this paper
• Antiretroviral Treatment for HIV Elite Controllers?

  2020cites this paper
• Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control

  2020cites this paper
• A Pilot Study of the Humoral Response Against the AntiSense Protein (ASP) in HIV-1-Infected Patients

  2020cites this paper
• Dynamics in HIV‐DNA levels over time in HIV controllers

  2019cites this paper
• A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation

  2019cites this paper
• Elevated Expression of miR-19b Enhances CD8+ T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral Suppression

  2019influential citation
• HIV controllers: to treat or not to treat? Is that the right question?

  2019cites this paper
• Learning From the Exceptions: HIV Remission in Post-treatment Controllers

  2019cites this paper
• Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers

  2019cites this paper
• Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

  2019cites this paper
• Rapid development of HIV elite control in a patient with acute infection

  2019cites this paper
• Cardiovascular events in the French ANRS HIV controller cohort.

  2019cites this paper
• A mechanistic investigation of T cell receptor-mediated HIV control

  2019cites this paper
• A role for antibodies in natural HIV control.

  2019cites this paper
• HIV-infection in children and adolescents in Zimbabwe: viral suppression, airway abnormalities and gut microbiota.

  2019cites this paper
• Transcriptional down-regulation of ccr5 in a subset of HIV+ controllers and their family members

  2019cites this paper
• HIV long-term non-progressors elite controllers: an interplay between host, immune and viral factors

  2019cites this paper
• Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control

  2019cites this paper
• High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.

  2019cites this paper
• The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients.

  2019cites this paper
• Elite suppressors have low frequencies of intact HIV-1 proviral DNA.

  2019cites this paper
• False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.

  2019cites this paper
• Immune Correlates of Natural HIV Elite Control and Simultaneous HCV Clearance—Supercontrollers

  2018cites this paper
• Proteomic Profile Associated With Loss of Spontaneous Human Immunodeficiency Virus Type 1 Elite Control

  2018cites this paper
• Factors predictive of virological failure on atazanavir in 310 HIV-infected patients

  2018cites this paper